Semaglutide and Cognition in Healthy Volunteers
NCT06363487
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
70
Enrollment
OTHER
Sponsor class
Conditions
Cognitive Change
Interventions
DRUG:
Semaglutide, 0.5 mg/mL
OTHER:
Placebo, 0.9% NaCl 1.5mL
Sponsor
University of Oxford
Collaborators
[object Object]